
zzso of zzso zzso zzso is a known complication in the therapy of zzso multiple sclerosis zzso zzso zzso zzso that can interfere with efficacy are zzso using in zzso zzso however, these zzso do not reveal the zzso state of the patient and are not zzso of treatment zzso 

Assessment of the impact of zzso on zzso responsive cells and zzso pathways in peripheral blood zzso cells zzso with zzso flow zzso 

zzso from 10 zzso patients with zzso two zzso patients, and two healthy controls were zzso in zzso zzso and media with a serial dilution of zzso zzso zzso and levels of zzso of zzso zzso factors were zzso in zzso zzso zzso zzso 0 to zzso zzso zzso zzso Data was subjected to principal component analysis, zzso T zzso and partial least squares zzso 

Three significantly distinct clusters of individuals were revealed in zzso zzso zzso and healthy, treated zzso and treated zzso Compared with controls zzso zzso patterns were modulated in treated zzso patients and inhibited in all treated zzso patients independently of zzso zzso In media no zzso of patients could be zzso The predictability of zzso zzso based on the zzso data was zzso 

zzso flow zzso can delineate zzso cell responses that can act as surrogates for zzso exposure in zzso zzso effects alter the response in primary cells even at low zzso zzso Cell zzso zzso testing is not readily zzso to the zzso response in zzso 

